1. Home
  2. NRXP vs FTHM Comparison

NRXP vs FTHM Comparison

Compare NRXP & FTHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • FTHM
  • Stock Information
  • Founded
  • NRXP 2015
  • FTHM 2010
  • Country
  • NRXP United States
  • FTHM United States
  • Employees
  • NRXP N/A
  • FTHM N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • FTHM Real Estate
  • Sector
  • NRXP Health Care
  • FTHM Finance
  • Exchange
  • NRXP Nasdaq
  • FTHM Nasdaq
  • Market Cap
  • NRXP 58.5M
  • FTHM 54.7M
  • IPO Year
  • NRXP N/A
  • FTHM 2020
  • Fundamental
  • Price
  • NRXP $2.92
  • FTHM $1.64
  • Analyst Decision
  • NRXP Strong Buy
  • FTHM Strong Buy
  • Analyst Count
  • NRXP 5
  • FTHM 1
  • Target Price
  • NRXP $31.40
  • FTHM $2.50
  • AVG Volume (30 Days)
  • NRXP 435.6K
  • FTHM 252.4K
  • Earning Date
  • NRXP 11-13-2025
  • FTHM 11-11-2025
  • Dividend Yield
  • NRXP N/A
  • FTHM N/A
  • EPS Growth
  • NRXP N/A
  • FTHM N/A
  • EPS
  • NRXP N/A
  • FTHM N/A
  • Revenue
  • NRXP N/A
  • FTHM $390,032,000.00
  • Revenue This Year
  • NRXP N/A
  • FTHM $25.22
  • Revenue Next Year
  • NRXP $395.09
  • FTHM $16.19
  • P/E Ratio
  • NRXP N/A
  • FTHM N/A
  • Revenue Growth
  • NRXP N/A
  • FTHM 19.16
  • 52 Week Low
  • NRXP $1.12
  • FTHM $0.65
  • 52 Week High
  • NRXP $6.01
  • FTHM $3.37
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 41.65
  • FTHM 44.81
  • Support Level
  • NRXP $3.05
  • FTHM $1.61
  • Resistance Level
  • NRXP $3.32
  • FTHM $1.84
  • Average True Range (ATR)
  • NRXP 0.22
  • FTHM 0.14
  • MACD
  • NRXP -0.05
  • FTHM 0.00
  • Stochastic Oscillator
  • NRXP 0.74
  • FTHM 26.32

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About FTHM Fathom Holdings Inc.

Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, insurance, and Software as a Service (SaaS) offering to brokerages and agents by leveraging proprietary cloud-based software, intelliAgent. The company has three reportable segments namely Real Estate Brokerage, Mortgage and Technology. The brands of the company include Fathom Realty, Dagley Insurance, Encompass Lending, intelliAgent, LiveBy, Real Results, and Verus Title. Majority of revenue is from Real Estate segment.

Share on Social Networks: